Global Recombinant Protein Expression System Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Recombinant Protein Expression System Market Research Report 2024
Proteins produced from such DNA templates are called recombinant proteins. Traditional strategies for recombinant protein expression involve transfecting cells with a DNA vector that contains the template and then culturing the cells so that they transcribe and translate the desired protein.
According to Mr Accuracy reports’s new survey, global Recombinant Protein Expression System market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Recombinant Protein Expression System market research.
Key companies engaged in the Recombinant Protein Expression System industry include Thermo Fisher, Merck, GenScript, Agilent, Takara Bio, Bio-Rad Laboratories, Qiagen N.V, Charles River and Sartorius, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Recombinant Protein Expression System were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Recombinant Protein Expression System market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Protein Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher
Merck
GenScript
Agilent
Takara Bio
Bio-Rad Laboratories
Qiagen N.V
Charles River
Sartorius
Corning
FUJIFILM Irvine Scientific
Lonza Group
Bioneer Corporation
Promega
Oxford Expression Technologies
ProteoGenix
Abeomics
New England Biolabs
Promab Biotechnologies
Sino Biological
Jena Bioscience
Lifesensors
Leading biology
Peak Proteins
Segment by Type
Mammalian Cell Expression System
Prokaryotic Expression System
Insect Cell Expression System
Yeast Expression System
Cell-free Expression System
Algal-based Expression System
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Recombinant Protein Expression System report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Recombinant Protein Expression System market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Recombinant Protein Expression System market research.
Key companies engaged in the Recombinant Protein Expression System industry include Thermo Fisher, Merck, GenScript, Agilent, Takara Bio, Bio-Rad Laboratories, Qiagen N.V, Charles River and Sartorius, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Recombinant Protein Expression System were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Recombinant Protein Expression System market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Protein Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher
Merck
GenScript
Agilent
Takara Bio
Bio-Rad Laboratories
Qiagen N.V
Charles River
Sartorius
Corning
FUJIFILM Irvine Scientific
Lonza Group
Bioneer Corporation
Promega
Oxford Expression Technologies
ProteoGenix
Abeomics
New England Biolabs
Promab Biotechnologies
Sino Biological
Jena Bioscience
Lifesensors
Leading biology
Peak Proteins
Segment by Type
Mammalian Cell Expression System
Prokaryotic Expression System
Insect Cell Expression System
Yeast Expression System
Cell-free Expression System
Algal-based Expression System
Segment by Application
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Recombinant Protein Expression System report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source